BioPharmCatalyst Profile Banner
BioPharmCatalyst Profile
BioPharmCatalyst

@BPharmCatalyst

28,731
Followers
234
Following
1,729
Media
11,328
Statuses

FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks

Solana Beach, CA
Joined July 2009
Don't wanna be here? Send us removal request.
Pinned Tweet
@BPharmCatalyst
BioPharmCatalyst
2 months
We have the replay! 🚀 Dive into the world of biotech with John from BPC and @VIPSheffTrades in our on-demand webinar. Unlock the best trading practices and leverage BioPharmCatalyst for your research. Watch it here:
0
1
8
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist Key Catalysts for Early 2023 $ANNX $ARDS $BCYC $CANF $CYTO $IMV $INZY $JSPR $ORMP $PGEN $PYPD $TSVT
Tweet media one
5
41
568
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist January 30, 2023: Key Catalysts due for February and March 2023 $TVTX $RETA $PHAR $EBS $CYTK $BPMC $APLS $INCY $CDTX $HALO $ACAD $RLYB $GILD $SNY $REGN $RDUS
Tweet media one
2
53
545
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist 02/18/23: Key phase 1/2 catalyst left for the 1Q $VKTX $FSTX $ASLN $ALT $ARMP $VTGN $TFFP $CYCN
Tweet media one
1
11
160
@BPharmCatalyst
BioPharmCatalyst
2 years
March 4, 2023: Key Upcoming Conference Catalysts to Watch $SRRK $ESPR $PDSB $CYTH $DICE $PBLA $AGEN $MLYS
Tweet media one
0
13
155
@BPharmCatalyst
BioPharmCatalyst
6 months
We are excited to offer our Elite Plus subscription at as low as $40/month* for the the upcoming #AACR2024 conference Our Elite & Elite Plus subscribers can access the AACR Dashboard here >>
Tweet media one
7
5
129
@BPharmCatalyst
BioPharmCatalyst
6 months
We are excited to announce an upcoming webinar!! Long-time biotech trader  @SheffStation joins @BPharmCatalyst to discuss conducting due diligence, how to best utilize #catalysts , & what to be excited about in the current #biotech landscape Register Now:
Tweet media one
5
10
125
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist February 27, 2023: Key PDUFA’s left for the 1Q $SNY $CYTK $AMGN $RETA $ACAD $CDTX $INCY $EBS $PHAR $REGN $BMRN $JAGX $PFE
Tweet media one
2
15
128
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist September 9, 2023: Key catalysts left for the quarter $OMER $BCLI $KOD $CRNX $INZY $CHRS $OCUP $FRTX $KRTX $SLNO $MREO $VXRT $ZVRA $CRDF $RLMD
Tweet media one
2
7
82
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist June 10, 2023: Key Catalysts Left, Countdown to the End of the Quarter $CRVS $GNFT $VNDA $BTAI $ALDX $TSHA $ATAI $ALZN $FBIO $BMEA
Tweet media one
0
8
77
@BPharmCatalyst
BioPharmCatalyst
1 year
August 5, 2023: Key Catalysts for the next 6 months $ALDX $CRMD $MRUS $AXSM $IMMP $PDSB $ADXS $GLTO $AMAM $IMGN $AGEN
Tweet media one
1
5
77
@BPharmCatalyst
BioPharmCatalyst
1 year
We are delighted to unveil our newest product, BPC Portfolios! A collection of portfolios with BPC's hand-selected tickers. Our flagship portfolio, BPC 50 tracks 50 tickers measured by relative strength to the market and respective catalysts $xbi #biotech
Tweet media one
2
6
68
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist June 24, 2023:Key Catalysts left for the Quarter: $CAPR $TVTX $AMRX $SRRK $AXSM $ARWR $VRNA $ARWR $VRNA $GNFT $ALDX $VTGN $TFFP $SONN $NGM $TSHA $PCSA $LUMO $APLT $HALO $BMEA $EWTX $ALZN $IVA $ABUS $FBIO $PHRRF $ICPT
Tweet media one
4
5
64
@BPharmCatalyst
BioPharmCatalyst
8 years
Feels great to get the new off the ground. See what's in store here
Tweet media one
7
15
67
@BPharmCatalyst
BioPharmCatalyst
7 years
15 of 50+ Biotech 3Q catalysts: $SAGE $ALNY $AVEO $AXON $FOLD $INSM $NBRV $NEOS $NVS $OTIC $PRQR $PTCT $VSAR $VSTM
1
28
63
@BPharmCatalyst
BioPharmCatalyst
2 months
Join 's webinar to explore the "hows" and "whys" of language models, driving groundbreaking research advancements. We dive deep. You emerge an expert. Save your spot:
Tweet media one
3
6
64
@BPharmCatalyst
BioPharmCatalyst
1 year
🎆 This Fourth of July, ignite your biotech research!🇺🇸 Enjoy unlimited access to 1000+ catalysts, model portfolios, hedge fund holdings and other trading tools. 🎇Limited time offer, so lock in your savings now!🎇 $XBI $IBB $LLY $SGTX $BTAI $IMNM
Tweet media one
9
4
41
@BPharmCatalyst
BioPharmCatalyst
3 years
#ESMO21 Recap 09/21/21: Price movements following major data releases and trial updates from #ESMO21 .
Tweet media one
2
9
54
@BPharmCatalyst
BioPharmCatalyst
9 years
Pleased to announce FDA Calendar + Pipeline database have been updated. 2015 IPOs added soon
1
20
44
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist March 25, 2023: Key Catalysts left for 1Q 2023 $BMEA $EBS $BOLT $MDNA $ANVS $MRKR $IOVA $VACC $JAGX $MREO $VKTX $VRTX $IMMX
Tweet media one
1
3
44
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist June 3, 2023: Key Catalysts left for the Quarter (Post-Earnings Updated List) $ATNM $FGEN $TVTX $ALDX $PFE $CRVS $GNFT $VNDA $BTAI $FBIO $BCRX
Tweet media one
0
0
40
@BPharmCatalyst
BioPharmCatalyst
1 year
#ASCO23 is set to commence today and we are offering our subscriptions plans at up to 50% OFF! Sign up or upgrade your account during the #ASCO2023 and lock in savings for up to a year! For a list of companies presenting at ASCO refer to our ASCO23
Tweet media one
1
1
41
@BPharmCatalyst
BioPharmCatalyst
7 years
4Q Biotech Catalysts $ABBV $ALXN $AXON $BLUE $CALA $CEMP $CRIS $CYTK $DBVT $EARS $FPRX $LOXO $PTI $RVNC +Wk in Rev
4
14
43
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist September 16, 2023: Key catalysts left for the quarter $SNDX $INZY $BLRX $GRCL $CHRS $OCUP $ARQT $ELTX $HOWL $CDTX $SPRY
Tweet media one
6
9
40
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist Key Phase 3 Catalyst to Watch for the Next 6 Month $OMER $ARAV $PRFX $RVPH $CING $ACHV $LIAN $FBIO $DERM $PXMD $BTAI
Tweet media one
2
5
41
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech updates a little late today...spent the day hiking. If you're up north and looking for some summer sun with a decent view then you should come on down and check us out #NewZealand #IshmusPeak #Wanaka #LakeHawea
Tweet media one
Tweet media two
Tweet media three
3
1
42
@BPharmCatalyst
BioPharmCatalyst
1 year
#PrimeDay is not just for $AMZN! Save on our newest features including BPC portfolios, hedge fund data and more! Don't miss this opportunity to gain an edge in the #biotech market. 🚀💸 $XBI $IBB $LABU $CVKD $RXRX $LMNL $AVRO $SILK Start your FREE trial:
Tweet media one
0
1
37
@BPharmCatalyst
BioPharmCatalyst
7 years
BioPharmCatalyst NEW tool: Track #Biotech intra-day: - Highest gainers - Greatest losers - Unusual Volume
5
10
36
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist June 17, 2023: Key Catalysts left for the Quarter $CAPR $TVTX $AMRX $SRRK $AXSM $ARWR $VRNA $GNFT $ALDX $VTGN $TFFP $SONN $NGM $TSHA $PCSA $SRPT $LUMO $APLT $HALO $BMEA $EWTX $ALZN $IVA $ABUS $FBIO $ICPT
Tweet media one
1
5
35
@BPharmCatalyst
BioPharmCatalyst
7 years
20 Micro/Small Cap Biotech Catalysts left for 1Q 2018. Will cover mid/large cap nxt wk: $AIMT $APRI $ARNA $BHVN $CDTX $DERM $ESPR $IMGN $KDMN $KMPH $KURA $MDGL $MRNS $MYOK $PCRX $SMMT $SRNE $TTPH $VYGR $ABIO
2
20
29
@BPharmCatalyst
BioPharmCatalyst
5 years
Happy Holidays to all. BioPharmCatalyst daily updates will be taking a short break over Christmas. Will be back on December 30.
4
0
34
@BPharmCatalyst
BioPharmCatalyst
21 days
Upcoming catalyst for $PDSB: Full Phase 2 data from the VERSATILE-002 trial will be presented at #ESMO2024 on Sept 13-17. #Biotech #Oncology See more from $PDSB:
Tweet media one
3
3
33
@BPharmCatalyst
BioPharmCatalyst
7 years
Upcoming key Phase 3 Biotech Catalysts left for 1Q + wk in Review: $AIMT $ANTH $BHVN $CLSD $DERM $ESPR $GWPH $IMGN $NBIX $NRBV (spring) $REGN $VBLT $VTVT
2
17
30
@BPharmCatalyst
BioPharmCatalyst
11 months
$SAVA announced a significant safety finding based on interim magnetic resonance imaging (MRI) brain data from Alzheimer's patients who are enrolled in a Phase 3 clinical trial of simufilam. The MRI data suggest simufilam is not associated with treatment-emergent amyloid-related
Tweet media one
0
10
32
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist February 4, 2023: Key Catalysts due for 2Q $CYCN $ASLN $ACHV $EVAX $HEPA $DBTX $HGEN $INO $NRXP $SLS $SRNE $TSHA $LXRX $VXRT
Tweet media one
2
6
25
@BPharmCatalyst
BioPharmCatalyst
3 years
@Biohazard3737 Using strictly mid cap = mkt cap < $10b: Approvals: 33/48 (69%) CRLs: 15/48 Not official - rough numbers only.
2
4
32
@BPharmCatalyst
BioPharmCatalyst
3 months
BioPharmCatalyst Weekly #Watchlist Key Catalyst Remaining for 2Q, Countdown to the End of the Quarter $GTHX $SVRA $NVCR $FGEN $PPBT $JAGX $PGEN $CADL $ANVS $SRPT $UNCY $SLN $THAR $BTAI
Tweet media one
0
5
30
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Stock Catalysts early 2018 (Jan/Feb focus): Jan $BLRX $TCON (ASCO GI abstracts out 1/16) $EIGR $SGYP $KDMN $PHMMF Feb $AIMT $EARS "Early 18" $MDGL $MRNS 1Q18 $BHVN $DERM
1
21
29
@BPharmCatalyst
BioPharmCatalyst
6 years
10 upcoming Small-Cap Phase 3 catalysts slated for 2Q; Biotech Week in Review $ZGNX $TGTX $CARA $ZEAL $AVEO $IMGN $ESPR $ATXI $CTIC $PFNX
2
15
27
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist July 17, 2023: Key PDUFA and regulatory catalysts for the next 6 months $ALDX $MESO $BCLI $IOVA $BLRX $MIRM $SWTX $GRTX $GSK $ANAB $TARS $OCUP $VALN $SPRY $CPRX $BMY
Tweet media one
2
10
26
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist February 13, 2023: Key phase 3 catalyst left for the 1Q $ATNM $IMGN $INO $EXEL $GNFT $ITCI $BCDA $SELB $CERE $PTCT $CYTH $RAIN $KRTX $PCRX $BCRX
Tweet media one
1
3
20
@BPharmCatalyst
BioPharmCatalyst
8 years
Biotech Stock Watch List 11/28~ + list of 17 recent Reverse Split stocks to keep on your low float radar.
2
8
22
@BPharmCatalyst
BioPharmCatalyst
7 years
10 Biotech Catalysts slated for January 2018: $KALA $RVNC $SAGE $VNDA $EIGR $AXSM $AXON $BOLD $LPCN $ARDM
3
14
23
@BPharmCatalyst
BioPharmCatalyst
8 years
First 2017 BPC Biotech Stock Watch List: Upcoming Jan events: $AGRX Ph3 $ITEK Ph3 $TENX Ph3 $PLX Ph2 (interim)
1
11
21
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Wk in Review 9/29+ upcoming biotech events- early Oct: $ACRX $AERI $CAPR $FENC $FOLD $FLXN $ONCE $RDHL $SRPT
0
12
23
@BPharmCatalyst
BioPharmCatalyst
6 years
Biotech updates 4/11: $BLCM clinical hold lifted +17% $ALXN to acquire Wilson Therapeutics $NVAX offering $CBAY +11% PBC data $ICPT -7% $SMMT data 3Q + $RETA $BVXV $NKTR pipeline updates
0
8
22
@BPharmCatalyst
BioPharmCatalyst
7 years
17 Key Biotech Stock Catalysts to watch in March + Biotech Wk in Review: $ANAB $ANTH $ARNA $BHVN $CDTX $CLSD $DERM $ESPR $GTHX $IMGN $MRNS $MYOK $REGN $TSRO $VBLT $VNDA $VYGR
0
6
20
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 07/23/20: $NVAX COVID vaccine data first wk Aug $MIST regulatory update +167% $CBAY clinical hold lifted +25% $ABUS patent win +120%; $MRNA -9% Pipeline updates $AMPE $ARAV $CORT $DVAX $INCY $MIST $MYOK $PIRS $VERU
2
15
20
@BPharmCatalyst
BioPharmCatalyst
7 years
Upcoming 1Q 2018 PDUFA and Advisory Committee dates; Biotech Wk in Review ~ 12/22: $ARDM $APRI $GILD $LLY $LPCN $KMPH $OTIC $PCRX $SGYP $VRTX
0
10
22
@BPharmCatalyst
BioPharmCatalyst
8 years
Upcoming 4Q catalysts. 40+ binary events left for 4Q Selection here $AKAO $ARDM $BLUE $CERC $FOLD $MDGN $OPHT $SGYP
1
10
21
@BPharmCatalyst
BioPharmCatalyst
5 years
Happy Thanksgiving to all - thank you for your feedback and use of BioPharmCatalyst. Next daily update will be on Monday (markets closed Thur, early close Fri 1pm).
3
0
21
@BPharmCatalyst
BioPharmCatalyst
9 years
Happy NY all! Still on track to have the FDA Calendar and Company Pipeline databases updated by Monday!
2
5
22
@BPharmCatalyst
BioPharmCatalyst
6 years
Biotech Stocks to watch at #aacr18 (April 14-16); Biotech Week in Review: $DVAX $BMY $MRK $ARQL $CLDX $TSRO $ONCS $TOCA $BPMC
2
13
21
@BPharmCatalyst
BioPharmCatalyst
7 years
Upcoming October biotech catalysts $ACRX $AERI $ALXN $ATRS $DBVT $FENC $LOXO ​$MYL $ONCE $PTCT +Biotech Wk in Review
0
7
21
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Review+ 12 catalysts left for Sept $ABUS/ $ALNY $AXON $BCRX $FCSC $FOLD $NBRV $PRQR $PTCT $RDHL $VSAR $ZGNX
0
7
17
@BPharmCatalyst
BioPharmCatalyst
9 years
Merry Xmas! Pleased to let readers know that BPC will resume all services Jan 4. Databases to be updated over Xmas.
7
7
21
@BPharmCatalyst
BioPharmCatalyst
5 months
Keep an eye on $CYTK - they are making waves in the treatment of diseases affecting muscle function. Aficamten is in late stage trials for Hypertrophic Cardiomyopathy #biotech #innovation #healthcare See their pipeline and upcoming 2Q catalysts here:
Tweet media one
1
4
21
@BPharmCatalyst
BioPharmCatalyst
5 years
Biotech updates 02/10 $ACST delay -25% $LOGC clinical hold -26% AH $GILD MCL PDUFA 8/10 $BHVN Ph3 fail -8% $AQST PDUFA 09/27 +18% $LLY $RHHBY AD fail $VTVT data +52%; $MREO +27% Stock offerings $CANF $MRNA $TBPH $XERS; Notes $COLL $RVNC $TRVN NDA resub
0
9
19
@BPharmCatalyst
BioPharmCatalyst
6 years
Next week details of BioPharmCatalyst Premium will be unveiled. What you see now will continue to be freely available, with premium users getting access to an enhanced FDA Calendar and other tools. Look forward to showing you more next week!
0
3
19
@BPharmCatalyst
BioPharmCatalyst
8 years
BioPharmCatalyst updates: $BMRN PDUFA 1/27/17. $SPPI Adcom 9/14 + updates for $AVXL $RARE $VNDA $VRTX
1
6
14
@BPharmCatalyst
BioPharmCatalyst
6 years
15 PDUFA/Advisory Committee dates slated for May/June: $AKAO $AMGN $ARRY $BMRN $DERM $DOVA $DRRX $GWPH $INCY $INSY $KTOV $LLY $PTIE $REPH $SCPH $TXMD $VRX
0
11
18
@BPharmCatalyst
BioPharmCatalyst
3 years
BioPharmCatalyst Updates 10/11/21: $OCUL Approval +15% $PTGX Hold removed +94% $SUPN Acquisition $ADMS +75% $PCRX Acquisition $FLXN +59% $PROG +59%; $TRVI +25% $IMRX -19%; $VYGR -14% Pipeline Updates: $MRK $LABP $PLX $AZN $ATNX $SRPT $AMTI $TPTX
2
2
16
@BPharmCatalyst
BioPharmCatalyst
3 months
$VRNA awaits FDA decision on June 26 for ensifentrine, a groundbreaking COPD therapy. With $901.89M in cash, they’re set for a strong future. Approval could make ensifentrine the first new inhaled #COPD treatment in 20+ years! #biotech
2
7
19
@BPharmCatalyst
BioPharmCatalyst
7 years
16 PDUFA/Adcom dates Aug/Sep+Wk in Review PDUFA $VRX $ADMS $AMGN $AZN $KMDA $MRK $NEOS $NVS ​Adcom: $GSK $PTCT +more
0
13
17
@BPharmCatalyst
BioPharmCatalyst
4 years
BioPharmCatalyst updates 02/01/21 $VIE acquired +52% $ARQT +ve data +30% $DVAX #CovidVaccine update +63% $APLT hold lifted +21% $ADMS FDA approval+15% $MTNB miss -34% $CNCE fail -28% $NVAX +21% momo+coverage $PRTA +29% AH Offerings $ARGX $ARQT $EYPT $RVMD
0
6
17
@BPharmCatalyst
BioPharmCatalyst
5 years
Biotech updates 12/09: $THOR acquired +171% $ARQL acquired +104% $XBIT $JNJ agreement +75% ASH: $FTSV +111%; $FATE +41% $DTIL -52%; $CNST -17% $SCYX offering -23% AH Pipeline updates $ABEO $ACHV $GRTS $KALV $MRNS $OBSV $OCGN $TGTX $SESN $SUPN
0
13
15
@BPharmCatalyst
BioPharmCatalyst
6 years
Biotech Wk in Review + 14 Biotech stocks with data slated for release in June: $ALDR $ARQL $AZN $CARA $GBT $GEMP $GLMD $GLPG $HRTX $OBSV $RYTM $SPHS $SRPT $RHHBY
0
12
18
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 07/21/20: $MESO AdCom August 13 $AUPH PDUFA (p/r) Jan 22 $CASI offering -10% AH $MGEN analyst coverage +9% $ALEC open label presntn Jul 28 $IMRN +42% Pipeline updates $ABBV $ALEC $ARCT $BHVN $CERC $CYDY $IFRX $IRWD $NMTR $NVS $PSTI
0
4
16
@BPharmCatalyst
BioPharmCatalyst
7 years
On track for a record breaking traffic day at Thanks all for reading!
2
2
17
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist April 15, 2023: Key Regulatory Catalyst to Watch for the Next 6 Months $MCRB $ISEE $BLRX $VRCA $GMDA $OPNT $OTLK $ALDX $SWTX $GRTX $SRPT $OCUP $IBRX $AGEN $BIIB
Tweet media one
0
4
18
@BPharmCatalyst
BioPharmCatalyst
8 years
Biotech Stock Watch List - Wk of 12/19: $ACAD Ph2 $ANTH $ITEK $LXRX $OTIC Ph3 $CEMP PDUFA $PTLA NDA acceptance
2
14
17
@BPharmCatalyst
BioPharmCatalyst
6 years
Biotech Updates 04/09: $AVXS +82% buyout $MNLO -77% $VTVT -65% fail $ACAD -23% safety concerns $ABBV MRK +ve data $AGIO $JNCE up on @ft_health $RDHL $CLSN $GTXI $NERV pipe updates
0
7
17
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Events left slated for Feb + Week in Review: $AMAG / $ATRS $AIMT $APRI $KDMN $KMPH $KURA $MRNS $NVAX $PCRX $SRNE $VRTX
2
8
16
@BPharmCatalyst
BioPharmCatalyst
3 years
BioPharmCatalyst updates 06/21/21: ​$TARS eyelash mite infestation data -17% $ARWR collab +5% $CTXR +15%; $AVXL +14%; $SAVA +13% $NTEC -17%; $APVO -14%; $MLND -13% Pipeline updates $AGIO $ANEB $AVXL $IMMP $INBX $MBRX $NXTC $OYST $RGLS $SRRA $TBPH $TNXP
1
5
18
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist May 6, 2023: Key Catalysts Due Next 6 Months $SRPT $XFOR $ALDX $LIAN $HALO $COGT $PTCT $LXRX $VRNA $MESO $SAGE $BIIB $GRTX $DCTH $ISEE $RVNC $NBIX $IBRX $LIFE
Tweet media one
0
5
16
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 06/29/20 $AKRO data Tue AH $ICPT CRL -40% $HRTX CRL -28% -> $PCRX +18% $KNSA data +13% $VRCA CMC issues -19% $OBSV data Jul 6 Offerings $ACHV $CRSP $LQDA $XLRN Pvte placemts $BNTX $TRPX Pipe updates $ALT $ITRM $MRK $NMTR $SGEN $TFFP $TNXP
0
4
17
@BPharmCatalyst
BioPharmCatalyst
4 years
BioPharmCatalyst updates 02/12/21 $GTHX FDA approval $PRTA upgrade +46% $MNKKQ PDUFA deferred #COVID19 $SESN update Feb 16 $LLY Tanezumab Adcom Mar 24 Offerings $CLBS $HEPA $PHIO $IMGN +30%; $FOLD -33% Pipeline updates $IMGN $KTRA $MACK $MDNA $OCUL $PFE
2
3
16
@BPharmCatalyst
BioPharmCatalyst
8 years
BPC Week in Review + Jan Event Watch List $DMTX HemB $FGEN Panc+Ph3 China Jan/Feb $NBIX Ph2 $SGYP PDUFA $TENX​ Ph3
1
19
16
@BPharmCatalyst
BioPharmCatalyst
8 years
10 Biotech Stocks to put on your Watchlist: $DPRX $DRRX $GNCA $KITE $MSTX $OPHT $OPXA $PTIE $PTN $VRTX
0
11
15
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst Weekly #Watchlist February 4, 2023: Key Catalysts due for 2Q $CYCN $ASLN $ACHV $EVAX $HEPA $DBTX $HGEN $INO $NRXP $SLS $SRNE $TSHA $LXRX $VXRT
Tweet media one
1
3
13
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 04/29 $GILD remdesivir #COVID19 data +6% $AVEO data at ASCO +26% $UTHR CRL $JAZZ Ph3 fail $GSK Niraparib sNDA Approval $FENC $SNDX offerings $TORC reverse merger +26% Pipeline updates $ALLO $APLS $ATNX $AZRX $BMRN $CMRX $CTMX $IOVA $MGNX
0
10
17
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 06/22/20: $MYOV Ph3 data Tue PM $KPTI FDA Approval $FPRX upgrade +45% $EVOK +62% $CLSN offering -20% Pipeline updates $ABBV $ARQT $AUPH $BNTX $CRBP $EVLO $ONTX $PFE $SWTX $ZIOP
0
5
17
@BPharmCatalyst
BioPharmCatalyst
5 months
BioPharmCatalyst Weekly #Watchlist Key Catalysts due by Mid-2024 $MRNS $APLS $ATAI $CGTX $HLVX $ANTA $CMMB $AGIO $TSBX $PFE $COYA $NKTX $LXEO $VTYX $JSPR
Tweet media one
3
3
17
@BPharmCatalyst
BioPharmCatalyst
7 years
10 Biotech Catalysts final wk June $ALDR $CARA $PBYI $ACHN $CYTR $GEMP $MTNB $NEOT $PTI $RARX +Biotech Wk in Review
1
7
15
@BPharmCatalyst
BioPharmCatalyst
2 months
$ADAP Ph 2 interim results for Lete-cel (IGNYTE-ESO) in sarcoma showed a 40% ORR, consistent across indications, with a median duration of response around 11 months. Full Ph 2 results expected late 2024. #Biotech
2
4
16
@BPharmCatalyst
BioPharmCatalyst
5 years
Biotech updates 04/15: $FCSC license agreement +43% $BPMX reverse split $RCKT offering $AXSM mid-stage endpt met+6% $BPTH +33% Pipeline updates $ACST $ADVM $ALLO $ALNY $APVO $ARWR $BOLD $DARE $EIDX $MNOV $NVS $ORTX $PRQR $SAVA $SLGL $SRNE $ZYME
1
3
16
@BPharmCatalyst
BioPharmCatalyst
3 years
BioPharmCatalyst updates 07/06/21: $PRVB CRL -26% $CCXI PDUFA date ext - Oct 7 $ADXS r/merger +23% $IDYA offering -10% AH $SNGX +26% $ONCS +24% AH $PASG -15% $HOWL -14% Pipeline updates $ADIL $ANIP $ASND $ELOX $IPHA $KURA $LGVN $MRK $OPNT $SEEL $TRIL
1
4
15
@BPharmCatalyst
BioPharmCatalyst
6 years
BioPharmCatalyst website is currently down. Investigating issue causing this. Apologies for the inconvenience caused at the start of the trading week. Will update as soon as I have news.
1
0
16
@BPharmCatalyst
BioPharmCatalyst
6 months
BioPharmCatalyst Weekly #Watchlist March 2, 2024: Key catalysts left for the quarter $OPTN $GERN $VNDA $AKBA $OCUL $PTCT $TSHA $AKRO $ALGS $AQST $DYN $VTYX $RNA $MNMD $STOK
Tweet media one
3
4
16
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Stock Updates 10/2: $MCRB $BHVN -ve data $RIGL no Adcom $KTOV PDUFA 5/31 $RDHL Ph3 RHB104 data mid'18 $ZGNX offering $VICL up on LUI $ECYT +157% joins biotech mkt craze + $ABUS $DVAX $JNJ $SGMO $SPHS $VBLT
0
13
16
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist May 13, 2023: Key Phase 3 catalysts left for the Next 6 Months (post-earnings updated list) $OMER $ARAV $PRFX $RVPH $CING $ACHV $LIAN $FBIO $DERM $PXMD $BTAI
Tweet media one
0
3
14
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Wk in Review + Watch List -15 JUL Catalysts $ACRX $ARNA $AZN $DVAX $IPCI $IRWD $NVS $OCUL $PBYI $PRTK +more
0
7
15
@BPharmCatalyst
BioPharmCatalyst
2 years
BioPharmCatalyst is the website for trading #biotech - Track +1300 drug and medical device catalysts from +800 companies - Analyze company cash data, upcoming IPOs and more - Connect to a community of traders Be There When it Happens:
3
1
16
@BPharmCatalyst
BioPharmCatalyst
1 year
BioPharmCatalyst Weekly #Watchlist August 12, 2023: Key Phase 3 catalysts left for the quarter $LIAN $IMGN $MRNA $ARQT $SLNO $AXSM $RVPH $OMER $KOD $CBAY $CRNX $FGEN $INO
Tweet media one
0
2
14
@BPharmCatalyst
BioPharmCatalyst
3 years
BioPharmCatalyst updates 06/18/21: $ORPH CRL -50% $CYTR -62% $TARS data Monday $ATHA -39% (Thu news - CEO on leave) $GERN +30%; $VERV +19%; $PDSB +16% $RPHM -17%; $ENTX -15%; Pipeline updates $EDSA $ISEE $PTIX -13%
1
6
16
@BPharmCatalyst
BioPharmCatalyst
2 years
Key PDUFAs and Regulatory catalysts to watch for the next 6 months $ACER $APLS $ARDX $BYSI $CKPT $EYEN $FOLD $GMDA $GRTX $ICPT $MDWD $PHAT $PRVB $YMAB Read more:
Tweet media one
Tweet media two
0
1
16
@BPharmCatalyst
BioPharmCatalyst
7 years
Biotech Wk in Review ~ 3/24 +TEN upcoming March/April biotech catalysts incl $AUPH $CARA $CRBP $NBIX $KPTI $PLX $PTI
0
10
14
@BPharmCatalyst
BioPharmCatalyst
7 years
12 #Biotech Ph3 data due 3Q $ALNY $AXON $FOLD $NBRV $OTIC $REGN $SAGE $VSAR $ZGNX +more; Biotech Wk in Review ~8/11
1
6
14
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 05/04/20: $STML acquired +155% $CVM reaches Ph3 targeted events -16% Offerings $INSM $NTEC $KMPH PDUFA Mar 2021 Pipeline updates $ACIU $ADRO $ADVM $CORT $KALA $KRYS $KURA $MRNS $NERV $RARE $RYTM
1
4
15
@BPharmCatalyst
BioPharmCatalyst
4 years
Biotech updates 08/17/20: $UBX mid-stage fail -67% $SNY to acquire $PRNB +9% Clinical holds $PSTX -32% AH; $APLT -12% PDUFA dates - $GTHX Feb 15; $MYOV Jun 1; $UTHR Apr Pipeline updates $ATOS $BLUE $NVAX $PGEN
0
7
15
@BPharmCatalyst
BioPharmCatalyst
8 months
BioPharmCatalyst Weekly #Watchlist December 30, 2023: Key Phase 3 catalysts for the next 6 months $SYRS $GLYC $ITRM $KALV $TCON $ANNX $PYPD $LYRA $AVIR $NRXP $ANVS $SAVA $AXSM $CMPS $SCPH
Tweet media one
0
2
15